Prognostic impact of six versus eight cycles of standard regimen in patients with diffuse large B-cell lymphoma: propensity score-matching analysis

BACKGROUND: R-CHOP-21 has been the standard treatment for diffuse large B-cell lymphoma (DLBCL), but there is a paucity of evidence focusing on the number of cycles of regimens. PATIENTS AND METHODS: We conducted a retrospective study to compare the effectiveness of six cycles of standard regimens v...

Descripción completa

Detalles Bibliográficos
Autores principales: Oiwa, K., Fujita, K., Lee, S., Morishita, T., Tsukasaki, H., Negoro, E., Hara, T., Tsurumi, H., Ueda, T., Yamauchi, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287142/
https://www.ncbi.nlm.nih.gov/pubmed/34271313
http://dx.doi.org/10.1016/j.esmoop.2021.100210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287142/
https://www.ncbi.nlm.nih.gov/pubmed/34271313
http://dx.doi.org/10.1016/j.esmoop.2021.100210

Ejemplares similares